← Back to home

GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION

Clinical trials for GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION explained in plain language.

Never miss a new study

Get alerted when new GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION trials appear

Sign up with your email to follow new studies for GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Targeted pill aims to stall a common brain Tumor's growth

Disease control Not yet recruiting

This study tests whether the experimental drug safusidenib can slow or stop the growth of a type of slow-growing brain tumor called grade 2 glioma that has a specific genetic change (IDH1 mutation). Participants have had surgery but no other treatments like chemotherapy or radiat…

Matched conditions: GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION

Phase: PHASE3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION

Get alerted when new GRADE 2 GLIOMA (ASTROCYTOMA OR OLIGODENDROGLIOMA) WITH AN IDH1 MUTATION trials appear

Targeted pill aims to stall a common brain Tumor's growth